David Humphreys

Company: UCB

Job title: Executive Director & Head of Antibody & Novel Therapeutics

Seminars:

Drug Format Mechanisms of Action to Treat Immunoglobulin Related Diseases: FcRn & FcGR Blockers, Ig DJegraders & Sweepers 3:00 pm

• Illustrate the increasing number and diversity of current and future therapeutic modality options for immunoglobulin-related diseases • Selected examples will be highlighted to illustrate the main axes of FcRn and FcGR blockers, immunoglobulin degrades, and antigen-specific approaches • Overview of key assets in the clinic and late-stage pre-clinicalRead more

day: Conference Day One